EDUCATIONJ.D., Georgia State University
University of Illinois at Urbana-Champaign
University of California, Davis
- U.S. Patent and Trademark Office
Robert A. Hodges, J.D., Ph.D.
Dr. Hodges has extensive scientific and technical expertise. This experience includes biological therapeutics, receptors, transport, cell signaling, diagnostic and prognostic markers and techniques, genomics, proteomics, transgenic and recombinant organisms, analytic techniques, and recombinant DNA products and procedures.
Dr. Hodges has appeared before the US Patent and Trademark Office in both ex parte and inter partes proceedings, including appeal hearings and interference hearings. He has served as lead counsel in and conducted a number of biotech interferences. Dr. Hodges knows from personal experience what is required to succeed at the USPTO. Prior to becoming an attorney, Dr. Hodges served as a USPTO Patent Examiner and a Patent Agent.
Dr. Hodges helps businesses solve their global patent challenges. He has prosecuted thousands of US and foreign-originated patents, ably steering his clients through the examination process. Dr. Hodges knows not only how to build protections for his clients’ IP, but also how to remove the obstacles that can stand in their way. Dr. Hodges assists his clients to make critical decisions around their innovations in order to maximize immediate and future asset value. He is dedicated to delivering patent prosecution advice at the highest level of sophistication and with the ultimate goal of enforceability.
Dr. Hodges earned his Ph.D. in Genetics from the University of California in 1981 and J.D. from Georgia State University in 2002. Dr. Hodges is included in The Best Lawyers in America as one of the best intellectual property lawyers in Atlanta in the area of Biotechnology Law (2007-08, 2011-17). He was also named to the 2005 Super Lawyers list as a “Rising Star.”
Dr. Hodges is an inventor in a number of patents, including:
- United States Patent No. 4,472,502 for “Malolactic Gene”
- United States Patent No. 5,496,714 for “Modification of Protein by Use of a Controllable Intervening Protein Synthesis”
- United States Patent No. 5,834,247 for “Modified Proteins Comprising Controllable Intervening Protein Sequences or Their Elements Methods of Producing Same and Methods for Purification of a Target Protein Comprised by a Modified Protein”